𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prognosis after resection of non-small cell lung cancer of the right middle lobe

✍ Scribed by Haran Peleg; Joseph G. Antkowiak; Warren W. Lane; Anne-Marie Regal; Hiroshi Takita

Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
303 KB
Volume
35
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Resection of stage III non-small cell lu
Resection of stage III non-small cell lung cancer following induction therapy
✍ Valerie W. Rusch πŸ“‚ Article πŸ“… 1995 πŸ› Springer 🌐 English βš– 779 KB

Approximately 25%-30% of all patients with non-small cell lung cancer (NSCLC) present with stage III tumors. Except for specific subsets, these tumors are not usually amenable to complete surgical resection and are associated with a 5-year survival of 10% or less. Because patients with stage III NSC

Overexpression of carbonic anhydrase XII
Overexpression of carbonic anhydrase XII in tissues from resectable non-small cell lung cancers is a biomarker of good prognosis
✍ Marius I. Ilie; VΓ©ronique Hofman; CΓ©cile Ortholan; Reda El Ammadi; Christelle Bo πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 French βš– 658 KB

## Abstract The pattern of protein expression in tumors is under the influence of nutrient stress, hypoxia and low pH, which determines the survival of neoplastic cells and the development of tumors. Carbonic anhydrase XII (CAXII) is a transmembrane enzyme that catalyzes the reversible hydration of